8450-107-530 3.0MM Precision Match Head, 13CM, single use, Sterile The Stryker MIS (Minimally In...
FDA Device Recall #Z-0868-2017 — Class II — November 30, 2016
Recall Summary
| Recall Number | Z-0868-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 30, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Stryker Instruments Div. of Stryker Corporation |
| Location | Portage, MI |
| Product Type | Devices |
| Quantity | 1,257 in total |
Product Description
8450-107-530 3.0MM Precision Match Head, 13CM, single use, Sterile The Stryker MIS (Minimally Invasive Surgery) product offering, is used to remove osseous material during surgical cases. Each cutting accessory consists of: " A shank (B) with a notch (A), that fits in the attachment on one end and is connected to the head of the bur on the other end. " A head (C) connected to the shank (B) and removes material using machined flutes. The head is machined directly on the shank/neck of the bur.
Reason for Recall
Stryker Instruments is voluntarily recalling specific lots of sterile MIS Toolsteel Burs because the burs may exhibit signs of corrosion.
Distribution Pattern
Worldwide Distribution - US (nationwide) including states of: AK, AL, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, MA, MD, ME, MI, MN, MO, NC, NE, NH, NJ, NM, NY, OH, OK, PA, SC, TN, TX, VA, WA, WI and countries of: Canada, Japan, Venlo (Netherlands), France, and UK (United Kingdom).
Lot / Code Information
Lot Number:16032017, Product Number: 8450-009-030
Other Recalls from Stryker Instruments Div. of Stryker C...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1452-2022 | Class II | SurgiCount+ System Application, Software Versio... | Jun 15, 2022 |
| Z-0431-2021 | Class II | Stryker Zyphr Disposable Cranial Perforator, La... | Oct 16, 2020 |
| Z-1807-2020 | Class II | Neptune E-SEP 165mm Blade Electrode, Catalog Nu... | Mar 26, 2020 |
| Z-1402-2022 | Class II | Triton Canister System (finished part numbers F... | Jan 22, 2020 |
| Z-1097-2020 | Class II | SafeAir Telescopic Smoke Evacuation Pencil, Pr... | Jan 13, 2020 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.